Publication

Cost-effectiveness of pneumococcal conjugate vaccine: evidence from the first 5 years of use in the United States incorporating herd effects

Rédigé par:

Ray G.T., Whitney C., Fireman B., et al.

Citation complète

Ray G.T., Whitney C., Fireman B., et al. 2006. Cost-effectiveness of pneumococcal conjugate vaccine: evidence from the first 5 years of use in the United States incorporating herd effects. Pediatric Infectious Disease Journal. 25(6).

Autres concepts clés de cette publication: